Virtual Psychiatric Care for Perinatal Depression
Virtual-PND
1 other identifier
interventional
76
1 country
2
Brief Summary
Perinatal depression occurs in 15% of pregnant women and new mothers, yet as few as 1 in 5 receive adequate treatment. It has a negative impact on the woman herself, as well as a potential for serious consequences for her child. Virtual psychiatric care is a potential model that may provide accessible mental health care during this time, as barriers to in-person care often include unpredictable infant schedules, competing childcare demands, or travel/cost challenges. The Virtual-PND intervention consists of 12-weeks of the option of supplementing in-person psychiatric care with secure, in-home real-time video-visits through the Ontario Telemedicine Network. This pilot RCT will demonstrate the feasibility of proceeding to a future large-scale RCT evaluation of virtual psychiatric care for this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedStudy Start
First participant enrolled
October 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFebruary 5, 2019
February 1, 2019
1.2 years
September 19, 2017
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Recruitment Feasibility (Recruitment Feasibility)
The number of women recruited to the study at each site
One year from when the study starts enrolling participants
Secondary Outcomes (10)
Edinburgh Postnatal Depressive Scale (EPDS)
At 12 weeks post-randomization
State-Trait Anxiety Inventory (STAI)
At 12 weeks post-randomization
Parenting Stress Index, Short Form (PSI)
At 12 weeks post-randomization
Recruitment Feasibility (Recruitment Eligibility)
One year from when the study starts enrolling participants
Recruitment Feasibility (Enrollment)
From enrollment to first treatment visit
- +5 more secondary outcomes
Study Arms (2)
Virtual Psychiatric Care Group
EXPERIMENTALParticipants randomized to the intervention group will have the option to receive video-based psychiatrist care in addition to care as usual. Participants will be assigned to begin immediately after randomization.
Control Group
NO INTERVENTIONWomen allocated to the control condition will receive care as usual (in-person psychiatric care) from the study site to which they were referred.
Interventions
Virtual psychiatric care for perinatal depression will be offered to participants, in addition to care as usual, for a 12-week period by their treating perinatal psychiatrist. Virtual care will be delivered by video-based visits through the Ontario Telemedicine Network (OTN). The treating psychiatrist may request that an intervention group participant present for in-person care at any visit, and this may include need for behavioural activation, or another health-related indication at the discretion of the treating psychiatrist.
Eligibility Criteria
You may qualify if:
- ≥18 years old
- Pregnant or 0-12 months postpartum
- Experiencing clinically significant depressive symptoms (defined as a score of ≥12 on the Edinburgh Postnatal Depressive Scale, EPDS, during eligibility screening)
- Able to access the internet on a device (i.e. mobile phone, tablet, personal computer) with video-visit capacity (including web camera and speakers)
- Comfortable with email communication
You may not qualify if:
- Active alcohol/substance use disorder in the past 12 months
- Active suicidal ideation
- Current mania or psychosis
- Unsuitable for virtual care, as per assessment of the treating psychiatrist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Women's College Hospitallead
- Sinai Health Systemcollaborator
Study Sites (2)
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Lori Wasserman, MD, FRCPC
Women's College Hospital
- PRINCIPAL INVESTIGATOR
Ariel Dalfen, MD, FRCPC
Sinai Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2017
First Posted
September 25, 2017
Study Start
October 24, 2017
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
February 5, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share